A recent study conducted by Dr. med. Michael Winkelmann and his colleagues at the LMU Klinikum München explored the association between TGR dynamics from pre-treatment to post-treatment imaging and the patients' outcomes.
The research provides valuable insights into the potential of TGR as a novel prognostic imaging biomarker in the context of CAR-T therapy for patients with relapsed or refractory non-Hodgkin's lymphoma.
Study with mint Lesion™ Uncovers the Impact of Tumor Growth Rate in Predicting the Efficacy of CAR-T-cell Therapy in Lymphoma Patients
Related Resources
Related Resources
Comparison of Diagnostic Guidelines for Hepatocellular Carcinoma
Recent advancements in MRI techniques and tumor biology have led to updated hepatocellular carcinoma (HCC) diagnostic guidelines from various liver…
RACOON: A Guide to Bridging the Gap Between Simulated and Real-World Federated Learning Research
Deep learning (DL) has become an important part of radiological image analysis. To train these deep-learning models, access to large and diverse…
RACOON: Study emphasizes the clinical relevance of pericardial effusion as an imaging biomarker in COVID-19 patients
A multicenter study [1] based on the German research infrastructure project RACOON (Radiological Cooperative Network of the COVID-19 pandemic; a Netzw…